Compliance to Synagis (Palivizumab) Under Daily Pediatrician´s Conditions in Premature Infants 33 - 35 wGA

CompletedOBSERVATIONAL
Enrollment

124

Participants

Timeline

Start Date

October 31, 2008

Primary Completion Date

May 31, 2011

Study Completion Date

May 31, 2011

Conditions
Premature Infants
Trial Locations (45)

1020

Site Reference ID/Investigator# 30845, Vienna

1030

Site Reference ID/Investigator# 30849, Vienna

Site Reference ID/Investigator# 40432, Vienna

Site Reference ID/Investigator# 40447, Vienna

1040

Site Reference ID/Investigator# 27773, Vienna

1060

Site Reference ID/Investigator# 52879, Vienna

1090

Site Reference ID/Investigator# 27769, Vienna

1100

Site Reference ID/Investigator# 40446, Vienna

Site Reference ID/Investigator# 52878, Vienna

1110

Site Reference ID/Investigator# 27774, Vienna

1120

Site Reference ID/Investigator# 27762, Vienna

1150

Site Reference ID/Investigator# 27763, Vienna

1190

Site Reference ID/Investigator# 40442, Vienna

1200

Site Reference ID/Investigator# 30851, Vienna

Site Reference ID/Investigator# 58942, Vienna

1210

Site Reference ID/Investigator# 30846, Vienna

Site Reference ID/Investigator# 30847, Vienna

Site Reference ID/Investigator# 57793, Vienna

1220

Site Reference ID/Investigator# 30852, Vienna

Site Reference ID/Investigator# 40425, Vienna

2020

Site Reference ID/Investigator# 30843, Hollabrunn

2230

Site Reference ID/Investigator# 40437, Gänserndorf

2491

Site Reference ID/Investigator# 48262, Neufeld

3002

Site Reference ID/Investigator# 27775, Purkersdorf

3100

Site Reference ID/Investigator# 30850, Sankt Pölten

3160

Site Reference ID/Investigator# 40439, Traisen

3270

Site Reference ID/Investigator# 27765, Scheibbs

3300

Site Reference ID/Investigator# 27772, Amstetten

Site Reference ID/Investigator# 52871, Amstetten

3400

Site Reference ID/Investigator# 27777, Klosterneuburg

Site Reference ID/Investigator# 30848, Tulln

3430

Site Reference ID/Investigator# 27776, Tulln

3500

Site Reference ID/Investigator# 30842, Krems

4020

Site Reference ID/Investigator# 52867, Linz

Site Reference ID/Investigator# 58943, Linz

4030

Site Reference ID/Investigator# 18603, Linz

4040

Site Reference ID/Investigator# 40445, Linz

Site Reference ID/Investigator# 52874, Linz

4060

Site Reference ID/Investigator# 27771, Leonding

4861

Site Reference ID/Investigator# 40440, Schörfling

6410

Site Reference ID/Investigator# 27764, Telfs

6800

Site Reference ID/Investigator# 52873, Feldkirch

7210

Site Reference ID/Investigator# 52870, Mattersburg

8750

Site Reference ID/Investigator# 27767, Judenburg

9020

Site Reference ID/Investigator# 27770, Klagenfurt

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Assign Data Management and Biostatistics GmbH

OTHER

lead

Abbott

INDUSTRY

NCT01077271 - Compliance to Synagis (Palivizumab) Under Daily Pediatrician´s Conditions in Premature Infants 33 - 35 wGA | Biotech Hunter | Biotech Hunter